Last $2.95 USD
Change Today 0.00 / 0.00%
Volume 61.1K
CYCC On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - cyclacel pharmaceuticals inc (CYCC)

Name (Connections)Board RelationshipsTitleKey Developments
Christopher Henney B.Sc. (Hons.), Ph.D., D.Sc. 81 RelationshipsVice Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation & Organizational Development CommitteeCyclacel Pharmaceuticals, Inc. announced delayed 10-Q filing
05/18/10
John Banham DL, MA, HonLLD, HonDSc 82 RelationshipsNon-Executive Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee 
Gregory Hradsky MBA 29 RelationshipsDirector and Member of Audit Committee 
Samuel Barker Ph.D. 53 RelationshipsDirector, Member of Audit Committee and Member of Compensation & Organizational Development Committee 

Compensation Committee* - cyclacel pharmaceuticals inc (CYCC)

Name (Connections)Board RelationshipsTitle
Nicholas Bacopoulos Ph.D. 14 RelationshipsDirector and Chairman of Compensation & Organizational Development Committee
Samuel Barker Ph.D. 53 RelationshipsDirector, Member of Audit Committee and Member of Compensation & Organizational Development Committee
Christopher Henney B.Sc. (Hons.), Ph.D., D.Sc. 81 RelationshipsVice Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation & Organizational Development Committee
David U'Prichard Ph.D. 181 RelationshipsChairman, Member of Compensation & Organizational Development Committee and Member of Nominating & Corporate Governance Committee
CYCC Compensation vs. Industry
515.1K
361.2K
Chief Executive Officer
334.4K
266.7K
Chief Financial Officer
Share price activity for CYCLACEL PHARMACEUTICALS INC (CYCC)
52 Week Price Performance
CYCC
Industry Average

Nominating Committee* - cyclacel pharmaceuticals inc (CYCC)

Name (Connections)Board RelationshipsTitleKey Developments
David U'Prichard Ph.D. 181 RelationshipsChairman, Member of Compensation & Organizational Development Committee and Member of Nominating & Corporate Governance CommitteeCyclacel Pharmaceuticals, Inc. Appoints Samuel L. Barker to the Board of Directors
09/11/14
Christopher Henney B.Sc. (Hons.), Ph.D., D.Sc. 81 RelationshipsVice Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation & Organizational Development CommitteeCyclacel Pharmaceuticals, Inc. Announces Resignation of Daniel K. Spiegelman from the Board
06/7/12
John Banham DL, MA, HonLLD, HonDSc 82 RelationshipsNon-Executive Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance CommitteeCyclacel Pharmaceuticals, Inc. Elects Sir John Banham and Daniel K. Spiegelman as Class 1 Directors
05/27/10
Lloyd Sems 30 RelationshipsDirector and Member of Nominating & Corporate Governance CommitteeCyclacel Pharmaceuticals Inc. Announces Resignation of John Womelsdorf as Vice President, Business Development
04/20/09

Corporate Governance Committee* - cyclacel pharmaceuticals inc (CYCC)

Name (Connections)Board RelationshipsTitle
John Banham DL, MA, HonLLD, HonDSc 82 RelationshipsDirector and Chairman of Compensation & Organizational Development Committee
Christopher Henney B.Sc. (Hons.), Ph.D., D.Sc. 81 RelationshipsDirector, Member of Audit Committee and Member of Compensation & Organizational Development Committee
Lloyd Sems 30 RelationshipsVice Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation & Organizational Development Committee
David U'Prichard Ph.D. 181 RelationshipsChairman, Member of Compensation & Organizational Development Committee and Member of Nominating & Corporate Governance Committee
CYCC and Competitor
Insiders vs. External
Board
14%
86%
Cyclacel Pharmaceuticals, Inc.
Insiders
External Board Members

Advisory Committee* - cyclacel pharmaceuticals inc (CYCC)

Name (Board Relationships)/Title Board Affiliations
Kenneth Harrap 13 Relationships
Member of Scientific Advisory Board
No other board affiliations
Stanley Kaye 66 Relationships
Member of Scientific Advisory Board
No other board affiliations
Michel Marty 41 Relationships
Member of Scientific Advisory Board
No other board affiliations
Enrico Mihich 13 Relationships
Member of Scientific Advisory Board
No other board affiliations
Karol Sikora 91 Relationships
Member of Scientific Advisory Board
No other board affiliations

Management/Organization Development Committee* - cyclacel pharmaceuticals inc (CYCC)

Name(Connections)Board RelationshipsTitle
Nicholas Bacopoulos Ph.D. 14 RelationshipsDirector and Chairman of Compensation & Organizational Development Committee
Samuel Barker Ph.D. 53 RelationshipsDirector, Member of Audit Committee and Member of Compensation & Organizational Development Committee
Christopher Henney B.Sc. (Hons.), Ph.D., D.Sc. 81 RelationshipsVice Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation & Organizational Development Committee
David U'Prichard Ph.D. 181 RelationshipsChairman, Member of Compensation & Organizational Development Committee and Member of Nominating & Corporate Governance Committee
Rank Against Competitors
Revenue/Employee
$60.2K-32768
Earnings/Employee
$998.6K32
K = Thousand
M = Million
B = Billion
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYCC:US $2.95 USD 0.00

CYCC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CYCC.
View Industry Companies
 

Industry Analysis

CYCC

Industry Average

Valuation CYCC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 37.5x
Price/Book 2.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 23.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYCLACEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.